Skip to content
OpenCapital
Get started

NewAmsterdam Pharma Company NAMS Market capitalization

Market capitalization at other companies

Merck & Co. logo
Merck & Co.MRK
$297.4B+31.2%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$3.04B+54.2%

Other financials

Income statement

See full
Revenue$3.0M+2.1%
Operating income-$58.4M+15.2%
Net income-$48.4M-22.6%
EPS (diluted)-$0.40-17.6%

Balance sheet

See full
Cash & equivalents$457.6M-38.9%
Total debt$23.0K-94.1%
Total equity$665.2M-14.4%
Total assets$732.6M-10.5%

Cash flow

See full
Operating cash flow-$30.6M+16.1%
CapEx$38.0K+138%
Free cash flow-$30.6M+16.0%

Profitability

See full
Operating margin-953.6%-3,536pp
Net margin-942.8%-3,477pp
FCF margin-630.1%-6,324pp

Returns & leverage

See full
Return on equity-29.5%-1.8pp
Current ratio9.8×-10.2×

Where this comes from

Computed from the period-end share price: $3.68B.

The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about NewAmsterdam Pharma Company's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NewAmsterdam Pharma Company's market capitalization?
NewAmsterdam Pharma Company (NAMS) reported market capitalization of $3.68B in Q1 2026.
How has NewAmsterdam Pharma Company's market capitalization changed year-over-year?
NewAmsterdam Pharma Company's market capitalization increased by 63.7% year-over-year, from $2.25B to $3.68B.
What is the long-term trend for NewAmsterdam Pharma Company's market capitalization?
Over 4 years (2021 to 2025), NewAmsterdam Pharma Company's market capitalization has grown at a 45.9% compound annual growth rate (CAGR), from $877.36M to $3.98B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.